Craft

FoRx Therapeutics

Total Funding

$10.8 M

FoRx Therapeutics Summary

Company Summary

Overview
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. The company focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
Type
Private
Status
Active
Founded
2019
HQ
Basel, CH | view all locations
Website
http://forxtherapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Florian Muellershausen

    Florian Muellershausen, Director

    • Colin Goddard

      Colin Goddard, Executive Chairman of the Board

      • Tarig Bashir
      • Therese Maria Liechtenstein

        Therese Maria Liechtenstein, Director

        LocationsView all

        1 location detected

        • Basel, BS HQ

          Switzerland

          210, Lichtstrasse 35

        News

        Footer menu